Results 181 to 190 of about 21,395 (260)

Soft tissue calcifications in chronic kidney disease-beyond the vasculature. [PDF]

Pflugers Arch
Fajol A, Faul C.
europepmc   +1 more source

Tumor Lysis Syndrome Triggered by Acalabrutinib in Chronic Lymphocytic Leukemia (CLL): Diagnostic and Therapeutic Implications. [PDF]

Cureus
Fadi M, Lahlou FA, El Ouafa Y, Chahdi H, Bouanani N.   +4 more
europepmc   +1 more source

PATHOGENESIS OF BONE AND MINERAL RELATED DISORDERS IN CHRONIC KIDNEY DISEASE: KEY ROLE OF HYPERPHOSPHATEMIA

, 2009
Pablo Román‐García, Natalia Carrillo‐López, Jorge B. Cannata‐Andía   +2 more
openalex   +2 more sources

Comparison of the efficacy of sucroferric oxyhydroxide and lanthanum carbonate in the hyperphosphatemia of maintainable Hemodialysis. [PDF]

BMC Pharmacol Toxicol
Li M, Kang Y, Zhang C, Ni X.
europepmc   +1 more source

Iron, Aluminum, and Lanthanum-based Drugs for Treatment of Hyperphosphatemia

, 2015
Kenji Matsumura
openalex   +2 more sources

Late-Onset Pseudohypoparathyroidism: A Case Report. [PDF]

Cureus
Ebrahim R, Peedika Parambil N, Poolakundan H, Dauda Sonibare A, Jenner Poolakundan F.   +4 more
europepmc   +1 more source

Pharmacological and clinical trial data on a novel phosphate-binding polymer (sevelamer hydrochloride), a medicine for hyperphosphatemia in hemodialysis patients.

, 2003
Nobuo Nagano, Naoshi Fukushima
openalex   +2 more sources

Effectiveness of Novel versus Conventional Phosphate Binder in Managing Hyperphosphatemia in Chronic Kidney Disease

Rajesh Hadia, Abhishek Patel, Divya Sharma, Shivangi Solanki, Cyril Sajan, Varunsingh Saggu, Hemraj Singh Rajput   +6 more
openalex   +1 more source

BACE2-Induced Aberrant Lymphatic Network Aggravates the Local Inflammation in Arteriovenous Fistulas With Hyperphosphatemia. [PDF]

Adv Sci (Weinh)
Chen K, Guan Z, Jin H, Aihemaiti M, Mou R, Yu M, Hu Y, Jiang L, Wang X, Yang H, Chen T, Lu Y, Zhang H, Xu Q, Li W.   +14 more
europepmc   +1 more source

Construction and validation of a predictive model for the serum phosphorus reduction after total parathyroidectomy in patients with secondary hyperparathyroidism. [PDF]

Front Endocrinol (Lausanne)
Feng Y, Zhou Y, Feng X, Sa Q, Zhang N, Xie W, Liu B, Chen F, Cheng G, Zhang W.   +9 more
europepmc   +1 more source